Chief Medical Officer
Langdon L. Miller, M.D. joined PTC as Chief Medical Officer in July 2003. From 1995 until July 2003, Dr. Miller served in various positions in the oncology clinical development, including as Vice President of Global Clinical Research, Oncology, at the Pharmacia Corporation. From 1989 to 1995 Dr. Miller served as a Senior Investigator at the National Cancer Institute. Dr. Miller received his M.D. degree from Northwestern University Medical School. He completed an internal medicine residency at the University of Minnesota and a medical oncology fellowship at Stanford University.